StemWave and Rehab Management Group Forge Exclusive Partnership to Revolutionize Orthopedic Care

August 18, 2023 10:09 AM AEST | By EIN Presswire
 StemWave and Rehab Management Group Forge Exclusive Partnership to Revolutionize Orthopedic Care
Image source: EIN Presswire

Cutting-edge Cellular Response Technology to be Offered at Special Pricing to Over 600 Partner Clinics Across the United States.

BOSTON, MASSACHUSETTES, UNITED STATES OF AMERICA, August 17, 2023/EINPresswire.com/ -- – StemWave, a pioneering medical device company specializing in innovative orthopedic shockwave technology, is thrilled to announce an exclusive partnership with Rehab Management Group, a leading provider of comprehensive rehabilitation solutions. This groundbreaking collaboration aims to transform orthopedic care across the United States by providing access to StemWave's state-of-the-art Cellular Response Technology at unprecedented pricing to Rehab Management Group's extensive network of over 600 partner clinics.

Cellular Response Technology, developed by StemWave, represents a revolutionary advancement in orthopedic shockwave therapy. This cutting-edge technology harnesses the body's natural healing processes to accelerate recovery and promote positive regenerative responses. By stimulating cellular activity at the molecular level, Cellular Response Technology delivers non-invasive, targeted treatments for a wide range of orthopedic conditions, including musculoskeletal injuries and chronic pain.

The strategic partnership between StemWave and Rehab Management Group will empower healthcare professionals across the country to offer their patients access to this transformative technology. StemWave's commitment to innovation aligns seamlessly with Rehab Management Group's mission to provide the highest quality rehabilitation services and optimize patient outcomes.

"We are excited to join forces with Rehab Management Group to bring Cellular Response Technology to a broader patient population," said Tom Kostopoulos, CEO at StemWave. "This partnership underscores our dedication to advancing orthopedic care and ensuring that more individuals have access to state-of-the-art treatments that can significantly improve their quality
of life."

Through this collaboration, StemWave and Rehab Management Group aim to elevate the standard of orthopedic care by making Cellular Response Technology more accessible and affordable to patients across the nation. The partnership will enable partner clinics to enhance their treatment offerings with a cutting-edge solution that has the potential to revolutionize the field of orthopedics.

"As a leader in rehabilitation services, we are always seeking innovative solutions to enhance the care we provide to our patients," said Charmaine Knapp, National Director of Clinical Training and Education at Rehab Management Group. "The addition of StemWave's Cellular Response Technology to our offerings aligns perfectly with our commitment to excellence and patient-centered care."

The exclusive pricing arrangement ensures that Rehab Management Group's partner clinics can seamlessly integrate Cellular Response Technology into their treatment protocols, offering patients a unique opportunity to experience the benefits of this groundbreaking therapy.

For more information about StemWave and Cellular Response Technology, visit stemwave.com.

About StemWave
StemWave is a cutting-edge medical device company specializing in orthopedic shockwave technology. The company's innovative Cellular Response Technology harnesses the body's natural healing mechanisms to accelerate recovery and promote positive regenerative responses. StemWave is committed to advancing orthopedic care through groundbreaking solutions that improve patient outcomes and quality of life.

Ava Williams
StemWave
+1 617-958-8572
[email protected]


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.